Journal
JOURNAL OF IMMUNOLOGY
Volume 167, Issue 11, Pages 6330-6337Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.167.11.6330
Keywords
-
Categories
Funding
- NCI NIH HHS [P01 CA69381] Funding Source: Medline
- NIAID NIH HHS [R01 AI33068] Funding Source: Medline
- NIDDK NIH HHS [R29 DK54451, P01 DK46763] Funding Source: Medline
Ask authors/readers for more resources
LIGHT, a member of the TNF family of cytokines (homologous to lymphotoxin, exhibits inducible expression and competes with HSV glycoprotein D for herpesvirus entry mediator, a receptor expressed on T cells), is induced on activated T cells and mediates costimulatory and antitumor activity in vitro. Relatively little information is available on the in vivo effects of LIGHT expression, particularly within the T cell compartment. In this work, we describe transgenic mice that express human LIGHT under the control of the CD2 promoter, resulting in constitutive transgene expression in cells of the T lymphocyte lineage. LIGHT-transgenic animals exhibit abnormalities in both lymphoid tissue architecture and the distribution of lymphocyte subsets. They also show signs of inflammation that are most severe in the intestine, along with tissue destruction of the reproductive organs. These LIGHT-mediated effects were recapitulated when immune-deficient mice were reconstituted with bone marrow from LIGHT-transgenic donor mice. T cells in the LIGHT-transgenic mice have an activated phenotype and mucosal T cells exhibit enhanced Th1 cytokine activity. The results indicate that LIGHT may function as an important regulator of T cell activation, and implicate LIGHT signaling pathways in inflammation focused on mucosal tissues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available